The primary mechanism of Bifidobacteria in treating NAFLD can be partly explained through the modulation of the AMPK/SREBP-1c and PPAR signaling pathways, as detailed in Table 2. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.